- Rapamycin: Drug Repurposing in SARS-CoV-2 Infection2021 | Faculty of Medicine in Hradec Králové
- Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner2016 | Central Library of Charles University
- Disease evolution and response to rapamycin in Activated Phosphoinositide 3-Kinase delta syndrome: the european society for immunodeficiencies-Activated Phosphoinositide 3-Kinase d syndrome registry2018 | Second Faculty of Medicine
- Determination of rapamycin in the whole blood by HPLC/UV technique +1Publication without faculty affiliation
- Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics2022 | Faculty of Medicine in Hradec Králové
- The Role of Green Tea Catechin Epigallocatechin Gallate (EGCG) and Mammalian Target of Rapamycin (mTOR) Inhibitor PP242 (Torkinib) in the Treatment of Spinal Cord Injury2023 | Second Faculty of Medicine
- Integrated actions of mTOR complexes 1 and 2 for growth and development of Dictyostelium2019 | Faculty of Science
- Involvement of mTOR Pathways in Recovery from Spinal Cord Injury by Modulation of Autophagy and Immune Response2021 | Second Faculty of Medicine
- MicroRNA-34a activation in tuberous sclerosis complex during early brain development may lead to impaired corticogenesis2021 | Second Faculty of Medicine
- Anti-Aging Drugs - Prospect of Longer Life?2018 | Publication without faculty affiliation
- Acute Conditioning of Antigen-Expanded CD8(+) T Cells via the GSK3β-mTORC Axis Differentially Dictates Their Immediate and Distal Responses after Antigen Rechallenge2020 | Second Faculty of Medicine
- TOR complex 2 (TORC2) in Dictyostelium suppresses phagocytic nutrient capture independently of TORC1-mediated nutrient sensing.2012 | Faculty of Science
- MTOR - the atractive and mysterious signal proteinPublication without faculty affiliation
- Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)2022 | Publication without faculty affiliation
- Modeling new therapies for infantile spasms2010 | Third Faculty of Medicine
- Activity of c-Src as a novel target for the inhibition of mTOR signaling in human diseasesPublication without faculty affiliation
- Molecular Mechanisms Underlying Intensive Care Unit-Acquired Weakness and Sarcopenia2022 | Third Faculty of Medicine, Central Library of Charles University
- Tryptophan: A unique role in the critically ill2021 | Third Faculty of Medicine, Central Library of Charles University
- Autophagy modulators influence the content of important signalling molecules in PS-positive extracellular vesicles2023 | First Faculty of Medicine
- Initial single-center experience-with sirolimus after lung transplantation2006 | Second Faculty of Medicine
- Src-dependent activation of the mTOR signaling in melanoma cells2012 | First Faculty of Medicine
- Inhibition of mTORC1 by SU6656, the Selective Src Kinase Inhibitor, Is Not Accompanied by Activation of Akt/PKB Signalling in Melanoma Cells2013 | First Faculty of Medicine, Third Faculty of Medicine
- Management of the metastatic renal cancer2023 | Faculty of Medicine in Hradec Králové
- Temsirolimus2008 | Third Faculty of Medicine
- mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis2022 | First Faculty of Medicine
- Frentizole derivatives with mTOR inhibiting and senomorphic properties2023 | Third Faculty of Medicine
- Everolimus in the treatment of metastatic renal cell cancer2014 | First Faculty of Medicine
- An overview of treatment modalities in neuroendocrine neoplasias2013 | First Faculty of Medicine
- News in the treatment of metastatic renal cell carcinoma2018 | First Faculty of Medicine